Revenue (Tables)

3 Months Ended

Mar. 31, 2018

disaggregated revenue [Line Items]

disaggregated revenue [Line Items]

The following tables disaggregate our revenue from contracts with customers by business and geographic region:

	Three Months Ended March 31,
Businesses(in millions)	2018		2017
Endoscopy
U.S.	$	231	$	215
International	187		164
Worldwide	418		379
Urology and Pelvic Health
U.S.	197		183
International	96		79
Worldwide	293		262
Cardiac Rhythm Management
U.S.	290		283
International	203		180
Worldwide	493		463
Electrophysiology
U.S.	35		32
International	39		32
Worldwide	75		64
Neuromodulation
U.S.	131		116
International	38		25
Worldwide	169		141
Interventional Cardiology
U.S.	281		278
International	364		312
Worldwide	645		590
Peripheral Interventions
U.S.	145		142
International	142		119
Worldwide	288		261
Total Company
U.S.	1,310		1,249
International	1,069		911
Net Sales	$	2,379	$	2,160

	Three Months Ended March 31,
Geographic Regions (in millions)	2018		2017
U.S.	$	1,310	$	1,249
EMEA (Europe, Middle East and Africa)	563		454
APAC (Asia-Pacific)	415		371
LACA (Latin America and Canada)	91		84
	$	2,379	$	2,160
Emerging Markets (1)	$	255	$	208